genetic screening

Malattie rare a cavallo dell’innovazione: una sfida etica e scientifica

A. Tommasini, A. Magnolato, S. Pastore, I. Bruno

2018/10 — pag. 628-634

Recent advances in medicine are providing new opportunities to treat rare and complex disorders. Precision therapies are being developed to target molecular processes crucial to the disease pathogenesis. Media often present technological advances r...

Dobbiamo dare il beta-bloccante a ogni bambino con il QT lungo?

V. Murgia

2015/6

DIV… ersi

I. Marinelli, M. Lepri

2013/9

Noè, Stocastica e la fibrosi cistica

B.M. Assael

2011/3 — pag. 182-184

Talassemia e bambini non natiCure semi-intensive e bisogni di salute inevasiFluoro nelle falde acquifere

2009/1 — pag. 13-15

Fibrosi cistica: dal gene alla pratica

L. Giglio, D. Faraguna

1999/1 — pag. 21-25

The identification of CF gene prompted several advances in the understanding of the disease, as well as practical improvements in the diagnosis. New perspectives are also open with respect to screening programs and therapeutic implications. At pres...